HealthEquity Inc (HQY)vsVeeva Systems Inc Class A (VEEV)
HQY
HealthEquity Inc
$81.02
-0.14%
HEALTHCARE · Cap: $6.80B
VEEV
Veeva Systems Inc Class A
$184.15
-0.78%
HEALTHCARE · Cap: $30.46B
Smart Verdict
WallStSmart Research — data-driven comparison
Veeva Systems Inc Class A generates 148% more annual revenue ($3.20B vs $1.29B). VEEV leads profitability with a 28.4% profit margin vs 14.9%. HQY appears more attractively valued with a PEG of 0.70. VEEV earns a higher WallStSmart Score of 69/100 (B-).
HQY
Buy64
out of 100
Grade: C+
VEEV
Strong Buy69
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+24.6%
Fair Value
$102.02
Current Price
$81.02
$21.00 discount
Margin of Safety
+29.2%
Fair Value
$249.97
Current Price
$184.15
$65.82 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 883.0% YoY
Growing faster than its price suggests
Strong operational efficiency at 24.8%
Conservative balance sheet, low leverage
Keeps 28 of every $100 in revenue as profit
Growing faster than its price suggests
Strong operational efficiency at 29.4%
16.0% revenue growth
Earnings expanding 23.5% YoY
Areas to Watch
Premium valuation, high expectations priced in
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : HQY
The strongest argument for HQY centers on EPS Growth, PEG Ratio, Operating Margin. PEG of 0.70 suggests the stock is reasonably priced for its growth.
Bull Case : VEEV
The strongest argument for VEEV centers on Debt/Equity, Profit Margin, PEG Ratio. Profitability is solid with margins at 28.4% and operating margin at 29.4%. Revenue growth of 16.0% demonstrates continued momentum.
Bear Case : HQY
The primary concerns for HQY are P/E Ratio.
Bear Case : VEEV
The primary concerns for VEEV are P/E Ratio.
Key Dynamics to Monitor
HQY profiles as a value stock while VEEV is a growth play — different risk/reward profiles.
VEEV carries more volatility with a beta of 1.12 — expect wider price swings.
VEEV is growing revenue faster at 16.0% — sustainability is the question.
VEEV generates stronger free cash flow (107M), providing more financial flexibility.
Bottom Line
VEEV scores higher overall (69/100 vs 64/100), backed by strong 28.4% margins and 16.0% revenue growth. HQY offers better value entry with a 24.6% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
HealthEquity Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
HealthEquity, Inc. provides technology-enabled service platforms to consumers and employers in the United States. The company is headquartered in Draper, Utah.
Veeva Systems Inc Class A
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America. The company is headquartered in Pleasanton, California.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?